Illinois Municipal Retirement Fund Iovance Biotherapeutics, Inc. Transaction History

Illinois Municipal Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$16.33 - $33.07 $149,174 - $302,094	-9,135 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$28.04 - $50.26 $128,142 - $229,688	4,570 Added 100.11%	9,135 $424,000
Q3 2020 Nov 03, 2020	BUY	$27.75 - $36.3 $126,678 - $165,709	4,565 New	4,565 $150,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Illinois Municipal Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Illinois Municipal Retirement Fund with notifications on news.